ARCHIVES

FDA Approves Lilly’s Alimta For Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

May 4, 2007

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

April 13, 1990

Managed Care Limits Access To Trials, Cancer Panel Says

August 11, 1995

In Brief: CRCC, One Of The 21 Comprehensive Centers, To Close Up; Steckel New AACI President

January 30, 1981

Gene Therapy Hyped By Scientists, Panel Tells NIH; Emphasis Must Be Basic Research

December 15, 1995

In Brief: GAO Says Scholarships And Loans Are Failures; Suggests Med Schools Need Facilities, Teachers

January 31, 1975